Table 4.

Proposed pathology results report

Identification of the patient and the doctor who ordered the test (or, failing that, the authorised person)

Pathological diagnosis

Type of specimen submitted:

Previous treatment (yes/no)   Time of biopsy (initial/relapse/progression)   Date on which the specimen was collected

The external code in the case of referral centres

The medium in which the specimen was received (fresh, frozen, paraffin-embedded, etc.)

The anatomical origin of the specimen

The order date, the specimen receipt date and the date on which the results were issued

The biomarker test method used, specifying detectable mutations and/or other abnormalities. In the case of commercial kits, the commercial name, the batch number and whether they are an approved ‘in vitro diagnostics’ product should be stated

The quality of the sample, specifying the percentage of cancer cells and whether the sample was enriched by micro- or macrodissection, as well as DNA concentration and purity

Comments about the adequate or inadequate nature of the sample

The test result, defining the type of molecular abnormality detected or the absence of molecular abnormalities

Identification of the professional responsible for the test (all phases)

Identification of the laboratory supervisor (optional)

Any additional information or comments of interest to the doctor who ordered the test

Accreditation or participation in quality programs